Mylan to pay $465 million over Medicaid overcharging
Drugmaker Mylan will pay $465 million to settle allegations that it overbilled Medicaid for its life-saving EpiPen, ending one of the controversies over the soaring price of the emergency allergy injection. The settlement with the Department of Justice follows news that EpiPen has been incorrectly classified since late 1997 as a generic product under...
I regard the brain as a computer which will stop working when its component fail. There is no heaven or afterlife for broken-down computers. That is a fairy story for people afraid of the dark